Autologous platelet rich gel in treatment of lower limb atherosclerotic occlusive disease in diabetic patients

Table 1 Demographic and clinical characteristics of study participants, n (%)

Variables	Intervention group (APRG)	Control group (SC)	P valuea
Age (years)	64.99 ± 15.31	64.79 ± 12.23	0.930
Female	31 (21.7)	33 (22)	0.417
Male	39 (26)	47 (31)
Weight (kg)	81.66 ± 15.6	80.27 ± 11.6	0.531
BMI (kg/m²)	27.89 ± 3.1	27.86 ± 4.1	0.981
Alcohol intake	9 (13)	5 (6.5)	0.145
Cigarettes	12 (8.1)	13 (8.7)	0.661
Physical activity (total MET)	35.21 ± 4.1	38.12 ± 4.1	0.156
SES
Low	34 (22)	45 (30)	0.221
Moderate	30 (20)	33 (22)
High	2 (2)	6 (4)
Duration of diabetes (years)	6.27 ± 0.41	6.3 ± 0.46	0.980
Medical adherence	7.99 ± 0.31	7.79 ± 0.24	0.855
Drugs
Insulin	17 (11)	15 (10)	0.250
Statins	65 (43)	78 (52)
Antihypertensive medications	35 (22.4)	46 (3.5)

^aP value < 0.05 typically indicates significance. A P value indicates the statistical significance of differences between groups.

SES: Socioeconomic status; APRG: Autologous platelet-rich gel; SC: Standard care; BMI: Body mass index.